We spoke to Enovis CEO Matt Trerotola about foundational implant technologies, ASC penetration, tech adoption and successful M&A deals.
We spoke to Enovis CEO Matt Trerotola about foundational implant technologies, ASC penetration, tech adoption and successful M&A deals.
Enovis reported 4Q22 orthopedic sales of $162.5 million, +10.4% compared to 4Q21. Including contributions from acquisitions, the company generated $599.4…
Our chart of the month shows the projected top 10 largest players in spine after recent M&A deals in the market segment.
Further, the USPTO intends to grant a patent for the conversion of the design from a hemi-arthroplasty to a total arthroplasty.
The system enables flexible treatment of fractures of the distal humerus and olecranon important to the elbow function and stability.
A new clinical study demonstrates Medacta’s MySpine accuracy in screw replacement during spine revision surgery.
The expanded clearance extends the clinical benefits of Precice to a wider range of patients, namely pediatrics.
The next iteration of HOLO Portal delivers advancements based on early clinical experience and insights from leading spine surgeons in the U.S.
Login
Register for a free account
As a guest member you get access to more articles and webinars every month.